Combining ranibizumab with calcium dobesilate to reduce injection frequency in diabetic macular edema treatment - Chen, Jian-Ying; Pan, Hong-Wei; Zhang, Xiao-Ming; Liu, Jing-Min; Chan, Sum-Yuet; Liu, Ting-Ting; Ma, Jian-yi; Liu, Qi; Yi, Wan-Zhao; Wu, Ya-Ni; Gu, Shuo-Shuo; Xia, Ling-Xiao; et al. (International ophthalmology, 2025)
Keywords: Acuity; Aged; Angiogenesis Inhibitors - administration & dosage; Calcium; Calcium Dobesilate - administration & dosage; Combination therapy; Comparative analysis; Diabetes mellitus; Diabetic Retinopathy - complications; Diabetic Retinopathy - diagnosis; Diabetic Retinopathy - drug therapy; Drug Therapy, Combination; Edema; Effectiveness; Female; Follow-Up Studies; Humans; Injection; Intravitreal Injections; Macula Lutea - pathology; Macular Edema - diagnosis; Macular Edema - drug therapy; Macular Edema - etiology; Male; Medicine; Medicine & Public Health; Middle Aged; Ophthalmology; Original Paper; Patients; Ranibizumab - administration & dosage; Therapy; Tomography, Optical Coherence - methods; Treatment Outcome; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Visual Acuity; Visual observation; Calcium dobesilate; Efficacy; Intravitreal injections; Diabetic macular edema; Ranibizumab